O
OS Therapies Incorporated (OSTX)
ASE – Real vaqt narxi. Valyuta: USD
1.88
+0.08 (4.44%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.84
-0.04 (-2.13%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
1.88
+0.08 (4.44%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.84
-0.04 (-2.13%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
OS Therapies Incorporated, klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda osteosarkoma va boshqa qattiq o'smalar uchun davolash usullarini aniqlash, ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniyaning portfelida osteosarkoma bemorlari uchun tayyor immünoterapiya bo'lgan OST-HER2; va sozlanishi mumkin pH sezgir silikon linkeri mavjud bo'lgan, plug-and-play platformali antikor-dorilangan konjugat (ADC) silikon dioksidi linker texnologiyasi bo'lgan OST-tunable drug conjugate (OST-tADC) mavjud. Kompaniya 2018 yilda tashkil etilgan va Grasonville, Merilendda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Craig Eagle M.D. | Chief Medical Advisor & Member of Strategic Advisory Board |
| Dr. Robert G. Petit II, Ph.D. | Chief Medical Officer & Chief Scientific Officer |
| Mr. Christopher P. Acevedo | Chief Financial Officer |
| Mr. Gerald E. Commissiong | Chief Business Officer |
| Mr. Jack Doll | Chief of Staff |
| Mr. Paul A. Romness M.P.H. | Founder, Chairman, President & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-18 | 10-Q | ea0290259-10q_ostherap.htm |
| 2026-05-15 | NT 10-Q | ea0291171-nt10q_ostherapies.htm |
| 2026-04-30 | 8-K | ea0288588-8k_ostherapies.htm |
| 2026-04-02 | 8-K | ea0284488-8k_ostherapies.htm |
| 2026-03-31 | 8-K | ea0283924-8k_ostherapies.htm |
| 2026-03-31 | 10-K | ea0283146-10k_ostherap.htm |
| 2026-03-06 | 8-K | ea0280014-8k_ostherapies.htm |
| 2026-02-13 | 8-K | ea0276846-8k_ostherap.htm |
| 2026-01-20 | D | |
| 2026-01-12 | 8-K | ea0272516-8k_ostherap.htm |